Discovery and optimization of adamantyl carbamate inhibitors of 11β-HSD1

被引:11
作者
Tice, Colin M. [1 ]
Zhao, Wei [1 ]
Krosky, Paula M. [1 ]
Kruk, Barbara A. [1 ]
Berbaum, Jennifer [1 ]
Johnson, Judith A. [1 ]
Bukhtiyarov, Yuri [1 ]
Panemangalore, Reshma [1 ]
Scott, Boyd B. [1 ]
Zhao, Yi [1 ]
Bruno, Joseph G. [1 ]
Howard, Lamont [1 ]
Togias, Jennifer [1 ]
Ye, Yuan-Jie [1 ]
Singh, Suresh B. [1 ]
McKeever, Brian M. [1 ]
Lindblom, Peter R. [1 ]
Guo, Joan [1 ]
Guo, Rong [1 ]
Nar, Herbert [2 ]
Schuler-Metz, Annette [2 ]
Gregg, Richard E. [1 ]
Leftheris, Katerina [1 ]
Harrison, Richard K. [1 ]
McGeehan, Gerard M. [1 ]
Zhuang, Linghang [1 ]
Claremon, David A. [1 ]
机构
[1] Vitae Pharmaceut, Ft Washington, PA 19034 USA
[2] Boehringer Ingelheim Pharma GmbH & Co KG, D-88400 Biberach, Germany
关键词
11 beta-Hydroxysteroid dehydrogenase; Diabetes; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; METABOLIC SYNDROME; GLUCOCORTICOID ACTION; VISCERAL OBESITY; MICE; DISEASE; POTENT; MODEL;
D O I
10.1016/j.bmcl.2010.08.142
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Synthesis of 2-adamantyl carbamate derivatives of piperidines and pyrrolidines led to the discovery of 9a with an IC50 of 15.2 nM against human 11 beta-HSD1 in adipocytes. Optimization for increased adipocyte potency, metabolic stability and selectivity afforded 11k and 11l, both of which were >25% orally bioavailable in rat. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6725 / 6729
页数:5
相关论文
共 32 条
[1]   Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs.: Discovery of potent and selective inhibitors of the 11β-hydroxysteroid dehydrogenase type 1 [J].
Barf, T ;
Vallgårda, J ;
Emond, R ;
Häggström, C ;
Kurz, G ;
Nygren, A ;
Larwood, V ;
Mosialou, E ;
Axelsson, K ;
Olsson, R ;
Engblom, L ;
Edling, N ;
Rönquist-Nii, Y ;
Öhman, B ;
Alberts, P ;
Abrahmsén, L .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (18) :3813-3815
[2]  
Boyle CD, 2008, CURR OPIN DRUG DISC, V11, P495
[3]   The human short-chain dehydrogenase/reductase (SDR) superfamily: A bioinformatics summary [J].
Bray, James E. ;
Marsden, Brian D. ;
Oppermann, Udo .
CHEMICO-BIOLOGICAL INTERACTIONS, 2009, 178 (1-3) :99-109
[4]   Blockade of glucocorticoid excess at the tissue level:: Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 as a therapy for type 2 diabetes [J].
Fotsch, Christopher ;
Wang, Minghan .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (16) :4851-4857
[5]   Generation of a set of simple, interpretable ADMET rules of thumb [J].
Gleeson, M. Paul .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (04) :817-834
[6]   Structural characterization and pharmacodynamic effects of an orally active 11β-hydroxysteroid dehydrogenase type 1 inhibitor [J].
Hale, Clarence ;
Veniant, Murielle ;
Wang, Zhulun ;
Chen, Michelle ;
McCormick, Jocelyn ;
Cupples, Rod ;
Hickman, Dean ;
Min, Xiaoshan ;
Sudom, Athena ;
Xu, Haoda ;
Matsumoto, Guy ;
Fotsch, Christopher ;
Jean, David J., Jr. ;
Wang, Minghan .
CHEMICAL BIOLOGY & DRUG DESIGN, 2008, 71 (01) :36-44
[7]   11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice [J].
Hermanowski-Vosatka, A ;
Balkovec, JM ;
Cheng, K ;
Chen, HY ;
Hernandez, M ;
Koo, GC ;
Le Grand, CB ;
Li, ZH ;
Metzger, JM ;
Mundt, SS ;
Noonan, H ;
Nunes, CN ;
Olson, SH ;
Pikounis, B ;
Ren, N ;
Robertson, N ;
Schaeffer, JM ;
Shah, K ;
Springer, MS ;
Strack, AM ;
Strowski, M ;
Wu, K ;
Wu, TJ ;
Xiao, JY ;
Zhang, BB ;
Wright, SD ;
Thieringer, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (04) :517-527
[8]  
Hoff E.D, 2005, US Appl, Patent No. 2005245532
[9]   Physiochemical drug properties associated with in vivo toxicological outcomes [J].
Hughes, Jason D. ;
Blagg, Julian ;
Price, David A. ;
Bailey, Simon ;
DeCrescenzo, Gary A. ;
Devraj, Rajesh V. ;
Ellsworth, Edmund ;
Fobian, Yvette M. ;
Gibbs, Michael E. ;
Gilles, Richard W. ;
Greene, Nigel ;
Huang, Enoch ;
Krieger-Burke, Teresa ;
Loesel, Jens ;
Wager, Travis ;
Whiteley, Larry ;
Zhang, Yao .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (17) :4872-4875
[10]   Inhibitors of 11β-HSD1: A Potential Treatment for the Metabolic Syndrome [J].
Jean, David J. St., Jr. ;
Wang, Minghan ;
Fotsch, Christopher .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (17) :1508-1523